1. Bolen, J., DeSeau, V., O'Shaughnessy, J., Amini, S.: Analysis of Middle Tumor 
Antigen and pp60c-src Interactions in Polyoma Virus-Transformed Rat Cells. J. 
Virology 61: 3299, 1987. 
2. O'Shaughnessy, J., DeSeau, V., Amini, S., Rosen, N., Bolen, J.: Analysis of the 
c-src Gene Product Structure, Abundance and Protein Kinase Activity in Human 
Neuroblastoma and Glioblastoma cells. Oncogene Research 2:1, 1987. 
3. Veillette, ‘A., O'Shaughnessy, J., Horak, I., De Seau, V., Bolen, J.: Coordinate 
alteration of pp60 c-src Abundance and c-src RNA Expression in Human 
Neuroblastoma Variants. Oncogene 4:421, 1989. 
4. Lehrer, S., O'Shaughnessy, J., Song, H. I: Activity of pp60 c-src Protein Kinase 
in Human Breast Cancer. The Mount Sinai Journal of Medicine 66: 83, 1989. 
5. O'Shaughnessy, J., Moscow, J., and Cowan, K.: Breast Cancer Into the 1990's 
in Molecular Foundations of Oncology, Samuel Broder, Editor. Williams and 
Wilkins, Baltimore, 1991, pp. 311-338. 
6. Ben-Baruch, N., O'Shaughnessy, J., Denicoff, A., Goldspiel, B., Cowan, K.: 
Phase II Trial of Fazarabine in Patients with Metastatic Colon Cancer. Journal 
of Investigational Drugs. In Press. 
7. O'Shaughnessy, J. A., Wittes, R. E., Burke, G., Friedman, M. A., Johnson, J. R., 
Niederhuber, J. E., Rothenberg, M. L., Woodcock, J., Chabner, B. A., Temple, R.: 
Commentary Concerning Demonstration of Safety and Efficacy of 
Investigational Anticancer Agents in Clinical Trials. Journal of Clinical 
Oncology 9:2225-2232, 1991. 
8. Read, E.J., O'Shaughnessy, J.A., Yu, M.Y., Fox, M.C., Denicoff, A.M., Cowan, 
K.H., Gress, R.E.: Flow Cytometric Quantitation of Circulating Hematopoietic 
Progenitor Cells in Breast Cancer Patients on Chemotherapy. In Bone Marrow 
Purging and Processing, Gee, AP, Gross, S, Worthington-White, DA, eds. Wiley 
Liss, New York pp523-530,1992. 
9. Pierce, L., Bader, J., Cowan, K., O'Shaughnessy, J., Swain, S., Lippman, M., 
Danforth, D., Steinberg, S., Venson, D., Ben-Baruch, N.: The Effect of Systemic 
Therapy upon Local-Regional Control in Locally Advanced Breast Cancer. 
International Journal of Radiation Oncology, Biology and Physics 
23:949-960,1992. 
10. Pestalozzi, B.C., Sotos, G.A., Choyke, P.L., Fisherman, J.S., Cowan, K.H., 
O'Shaughnessy, J.A.: Typhlitis Resulting from Treatment with Taxol and 
Doxorubicin in Patients with Metastatic Breast Cancer. Cancer 
71:1797-1880,1993. 
1 1 . Fisherman, J.S., McCabe, M., Hillig, M., Goldspiel, B., Venzon, D.J., Cowan, 
K.H., and O'Shaughnessy, J.A. Phase I Study of Taxol Plus Doxorubicin Plus 
Granulocyte Colony-Stimulating Factor (G-CSF) in Patients with Metastatic 
Breast Cancer. J. Natl. Cancer Inst. In Press. 
12. Savarese, D.M., Denicoff, A.M., Berg, S.L., Hillig, M., Baker, S.P., 
O'Shaughnessy, J.A., Otterson, G.A., Balis, F.M., Poplack, D.G., Cowan, K.H., A 
Phase I and Pharmacokinetic Study of High Dose Piroxantrone Along with 
Granulocyte Colony-Stimulating Factor (G-CSF). J. Clin. Oncol. In Press. 
13. Berg, S.L., Savarese, D.M.F., Balis, F.M., Denicoff, A.M., Hillig, M., 
O'Shaughnessy, J.A., Poplack, D.G., Cowan, K.H. Pharmacokinetics of 
Piroxantrone in a Phase I Trial of Piroxantrone and Granulocyte 
Colony-Stimulating Factor. Cancer Res. 53:2587-2590,1993. 
[300] 
Recombinant DNA Research, Volume 18 
